Model
Edge
Ultragenyx Pharmaceutical Inc.
0001713070
Filing Type
4
Filing Date
6/8/2023
Updated
6/9/23, 8:30 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership